New Results
High level production and characterization of truncated human angiotensin converting enzyme 2 in Nicotiana benthamiana plant as a potential therapeutic target in COVID-19
Tarlan Mamedov, İrem Gürbüzaslan, Merve Ilgin, Damla Yuksel, Gunay Mammadova, Aykut Ozkul, Gulnara Hasanova
doi: https://doi.org/10.1101/2021.05.17.444533
Tarlan Mamedov
1Akdeniz University, Department of Agricultural Biotechnology, Dumlupınar Boulevard 07058 Campus, Antalya, Turkey
2Azerbaijan National Academy of Science, Department of Biology and Medical Science, 24 Istiglaliyyat Street, Baku, Azerbaijan
İrem Gürbüzaslan
1Akdeniz University, Department of Agricultural Biotechnology, Dumlupınar Boulevard 07058 Campus, Antalya, Turkey
Merve Ilgin
1Akdeniz University, Department of Agricultural Biotechnology, Dumlupınar Boulevard 07058 Campus, Antalya, Turkey
Damla Yuksel
1Akdeniz University, Department of Agricultural Biotechnology, Dumlupınar Boulevard 07058 Campus, Antalya, Turkey
Gunay Mammadova
1Akdeniz University, Department of Agricultural Biotechnology, Dumlupınar Boulevard 07058 Campus, Antalya, Turkey
Aykut Ozkul
1Akdeniz University, Department of Agricultural Biotechnology, Dumlupınar Boulevard 07058 Campus, Antalya, Turkey
3Department of Virology, Faculty of Veterinary Medicine, Ankara University, Ankara 06110, Turkey
4Biotechnology Institute, Ankara University, Ankara 06135, Turkey
Gulnara Hasanova
1Akdeniz University, Department of Agricultural Biotechnology, Dumlupınar Boulevard 07058 Campus, Antalya, Turkey
Article usage
Posted May 17, 2021.
High level production and characterization of truncated human angiotensin converting enzyme 2 in Nicotiana benthamiana plant as a potential therapeutic target in COVID-19
Tarlan Mamedov, İrem Gürbüzaslan, Merve Ilgin, Damla Yuksel, Gunay Mammadova, Aykut Ozkul, Gulnara Hasanova
bioRxiv 2021.05.17.444533; doi: https://doi.org/10.1101/2021.05.17.444533
High level production and characterization of truncated human angiotensin converting enzyme 2 in Nicotiana benthamiana plant as a potential therapeutic target in COVID-19
Tarlan Mamedov, İrem Gürbüzaslan, Merve Ilgin, Damla Yuksel, Gunay Mammadova, Aykut Ozkul, Gulnara Hasanova
bioRxiv 2021.05.17.444533; doi: https://doi.org/10.1101/2021.05.17.444533
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8749)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12086)
- Cell Biology (17403)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16795)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11582)
- Neuroscience (60936)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10423)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)